MDT

86.14

-0.25%↓

114.53

+0.54%↑

VEEV

172.83

-1.41%↓

HQY

83.37

+0.23%↑

PHR.US

8.39

+0.72%↑

MDT

86.14

-0.25%↓

114.53

+0.54%↑

VEEV

172.83

-1.41%↓

HQY

83.37

+0.23%↑

PHR.US

8.39

+0.72%↑

MDT

86.14

-0.25%↓

114.53

+0.54%↑

VEEV

172.83

-1.41%↓

HQY

83.37

+0.23%↑

PHR.US

8.39

+0.72%↑

MDT

86.14

-0.25%↓

114.53

+0.54%↑

VEEV

172.83

-1.41%↓

HQY

83.37

+0.23%↑

PHR.US

8.39

+0.72%↑

MDT

86.14

-0.25%↓

114.53

+0.54%↑

VEEV

172.83

-1.41%↓

HQY

83.37

+0.23%↑

PHR.US

8.39

+0.72%↑

Inicio・Lista de Acciones・Avita Therapeutics Inc

Avita Therapeutics Inc

Cerrado

3.75 1.35

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

3.69

Máximo

3.88

Métricas clave
By Trading Economics
Ingresos	1.6M -12M
Ventas	554K 18M
Margen de beneficios	-65.968
Empleados	226
EBITDA	1.6M -9.7M

Recomendaciones
By TipRanks
Recomendaciones	Comprar
Estimación a 12 Meses	+71.08% upside

Dividendos
By Dow Jones
Próximas Ganancias	7 may 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	-12M 111M
Apertura anterior	2.4
Cierre anterior	3.75

Puntuación técnica

By Trading Central

Confianza

Very Strong Bearish Evidence

8.83 / 9.77 Soporte y Resistencia

Avita Therapeutics Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

1 abr 2026, 22:56 UTC

Noticias de Eventos Importantes

Australian PM Set To Announce Interest-Free Loans For Businesses, Farmers

1 abr 2026, 20:50 UTC

Adquisiciones, fusiones, absorciones

Gilead Extends Deadline on Tender Offer to Acquire Arcellx

1 abr 2026, 23:55 UTC

Charlas de Mercado

Gold Rises on Hopes for Early End to U.S.-Iran Conflict -- Market Talk

1 abr 2026, 23:43 UTC

Charlas de Mercado

Nikkei May Rise on Continued Hopes for U.S. Ending Iran War -- Market Talk

1 abr 2026, 23:23 UTC

Noticias de Eventos Importantes

South Korea Consumer Inflation Accelerates on Mideast Energy Shock -- Update

1 abr 2026, 23:07 UTC

Ganancias

Shake Shack Leans on Loyalty Program and Tech to Drive Growth -- Barrons.com

1 abr 2026, 23:02 UTC

Noticias de Eventos Importantes

South Korea Consumer Inflation Accelerates on Mideast Energy Shock

1 abr 2026, 23:00 UTC

Noticias de Eventos Importantes

S Korea Mar CPI +0.3% on Month; +0.6% Forecast

1 abr 2026, 23:00 UTC

Noticias de Eventos Importantes

S Korea Mar Core CPI +2.2% on Year, +0.1% on Month

1 abr 2026, 23:00 UTC

Noticias de Eventos Importantes

S Korea Mar CPI +2.2% on Year; +2.4% Forecast

1 abr 2026, 22:39 UTC

Ganancias

Nike Can't Fix Its China Problem and That's Tanking Its Stock -- Update

1 abr 2026, 22:08 UTC

Charlas de Mercado

KKR BDC Joins Others in Capping Withdrawals at 5% -- Market Talk

1 abr 2026, 22:00 UTC

Noticias de Eventos Importantes

Mideast War Rekindles Asia Inflation Risk, Says DBS Chief Economist -- Interview

1 abr 2026, 22:00 UTC

Noticias de Eventos Importantes

DBS Chief Economist: Rate Hikes Seem Likely in Japan, Singapore, Australia

1 abr 2026, 22:00 UTC

Noticias de Eventos Importantes

DBS Chief Economist: BOK Could Also Take Proactive Approach Like RBA

1 abr 2026, 22:00 UTC

Noticias de Eventos Importantes

DBS Chief Economist: India Vulnerable to War Imapct on Both Trade, Energy

1 abr 2026, 22:00 UTC

Noticias de Eventos Importantes

DBS Chief Economist: China, Malaysia Looks Relatively Well-Insulated From War Fallout

1 abr 2026, 22:00 UTC

Noticias de Eventos Importantes

DBS Chief Economist: Mideast Crisis Won't Hurt Asia Growth Much, Inflation a Bigger Issue

1 abr 2026, 22:00 UTC

Noticias de Eventos Importantes

Inflationary Impact of Mideast Conflict Seems Inevitable, DBS Group Chief Economist Says

1 abr 2026, 21:56 UTC

Adquisiciones, fusiones, absorciones

BHP Completes $4.3 Billion Silver Streaming Agreement With Wheaton Precious Metals

1 abr 2026, 21:31 UTC

Noticias de Eventos Importantes

End to Iran War Could Trigger Relief Rally in These 2 Assets -- Barrons.com

1 abr 2026, 20:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

1 abr 2026, 20:50 UTC

Charlas de Mercado

Health Care Roundup: Market Talk

1 abr 2026, 20:38 UTC

Ganancias

Why Nike Stock Is in 'Penalty Box' After Earnings Beat -- Barrons.com

1 abr 2026, 20:31 UTC

Adquisiciones, fusiones, absorciones

Arsenal Capital Partners Completes Sale of ATP Adhesive Systems to Henkel

1 abr 2026, 20:16 UTC

Adquisiciones, fusiones, absorciones

Gilead: Tender Offer Extended to Expire at 5 p.m. EDT on April 24 >GILD

1 abr 2026, 20:16 UTC

Adquisiciones, fusiones, absorciones

Gilead: Offer Remains at a Purchase Price of $115.00 per Shr >GILD

1 abr 2026, 20:13 UTC

Adquisiciones, fusiones, absorciones

Gilead Extends Tender Offer To Acquire Arcellx >GILD

1 abr 2026, 20:07 UTC

Charlas de Mercado

Mexican Manufacturing Indexes Pick Up in March -- Market Talk

1 abr 2026, 20:07 UTC

Adquisiciones, fusiones, absorciones

Why 2026 Is Biotech's Comeback Year -- Barrons.com

Comparación entre iguales

Cambio de precio

Avita Therapeutics Inc previsión

Precio Objetivo

By TipRanks

71.08% repunte

Estimación a 12 Meses

Media 6.33 USD 71.08%

Máximo 10 USD

Mínimo 3.5 USD

De acuerdo con 4 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Avita Therapeutics Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

4 ratings

Comprar

Mantener

Vender

De acuerdo con 4 analistas que ofrecen calificaciones bursátiles a para Avita Therapeutics Inc Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

8.83 / 9.77Soporte y Resistencia

Recent bearish events outweigh bullish events.

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Avita Therapeutics Inc

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.